Navigation Links
Update: Number of Stryker Rejuvenate Hip Recall Lawsuits Growing in New Jersey Multicounty Litigation, Announces Wright & Schulte LLC
Date:3/17/2013

t tissue surrounding the implant and joint, as well as implant loosening, device failure and the need for revision surgery. The FDA has also warned that debris shed from metal hip implant components will enter the bloodstream and travel to other parts of the body, where it may cause systemic reactions in other tissue and organs.
( fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm335775.htm )

Stryker announced earlier this year that Broadspire Services, Inc., a third-party claims administrator, will handle reimbursement for testing, revision surgery, and out-of-pocket expenses relating to the Rejuvenate and ABG II recall. However, because any information disclosed in the process of filing a claim with Broadspire could be used in future Stryker hip implant lawsuits, Wright & Schulte LLC is recommending affected patients speak with an attorney before they communicate with Broadspire in any way, to ensure their legal rights are protected.
( aboutstryker.com/modularneckstems/ )

About Wright & Schulte LLC
Wright & Schulte LLC, a leading personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Stryker Rejuvenate and ABG II lawsuit case evaluations are available through yourlegalhelp.com, or call 1-800-399-0795

Contact:
Wright Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795

Read the full story at http://www.prweb.com/releases/2013/3
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HRT Update: Therapy May Reduce Fractures, Boost Some Risks
2. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
3. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
4. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
5. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
6. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
7. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
8. Research update: Chemists find help from nature in fighting cancer
9. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
10. Tylenol Liver Failure Allegation Lawsuits Update: Resource4thePeople Reports Hearing to Consolidate Federal Cases Is Scheduled
11. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... doTERRA, the leading global essential oils company, is ... recently, Jowers held the position as Director of the Hinckley Institute at the University ... building the institute, Jowers states that he was ready for a new challenge, and ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Seedstock today announced ... keynote address at the 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation and the ... conference , held at the University of California-San Diego, will explore solutions and methodologies ...
(Date:7/6/2015)... ... July 06, 2015 , ... MD Now, the leading and fastest-growing urgent ... constructed urgent care center will serve residents and visitors in the Cutler Bay area, ... Now’s 22nd South Florida location, the new facility will be the fourth to serve ...
(Date:7/6/2015)... ... July 06, 2015 , ... The ... grant funds to support a three-year effort to reduce rates of diabetes and ... conducted in partnership with the Morehouse School of Medicine’s Prevention Research Center and ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a ... selected Aspect Software Unified IP contact center solution hosted by Promero. Randstad ... IP as its future call center platform. , Promero will implement and ...
Breaking Medicine News(10 mins):Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3
... BOSTON, Mass. (Nov. 29, 2007)Sometimes healthy cells commit suicide. ... programmed cell death called apoptosis plays a key role ... or Medicine recognized their work. As apoptotic cells degrade, ... membrane and nuclear fragmentation. , Now, Harvard Medical School ...
... million men and women in the United States live ... that permeates muscles in the neck, back and shoulders. ... understood, but research studies indicate that a new imaging ... definitive diagnosis and, perhaps eventually, new treatments for people ...
... during a CT scan, and the masses look benign, ... a recent study conducted by researchers at Brown University ... of CT, we are frequently encountering findings that are ... so called incidentalomas, of which adrenal masses are quite ...
... 29% ... From Prior Year, LARGO, ... Venture Exchange: UVI), which develops,licenses, manufactures, distributes and markets specialty contact ... Net sales, excluding royalty income, for the quarter ended September,30, ...
... Medical International Inc., OTTAWA, Nov. 29 /PRNewswire-FirstCall/ ... and radiopharmaceuticals, today signed an,agreement with Best Medical ... self-contained irradiator product lines. The sale is a ... its resources on being a leading,innovator in molecular ...
... Jersey,s,hospitals suffered a 1 percent decrease in year-end ... of the New Jersey Hospital,Association,s 2007 Financial Status ... hospital profit margins have been at less than ... from audited financial data submitted by acute care ...
Cached Medicine News:Health News:Homeless cells find temporary lodging -- and their demise 2Health News:Homeless cells find temporary lodging -- and their demise 3Health News:MRE could provide a definitive diagnosis for people with muscle pain, Mayo Clinic study shows 2Health News:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Health News:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Health News:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Health News:MDS Nordion Divests Non Strategic Product Lines 2Health News:New Jersey Hospitals Post Razor Thin 0.6 Percent Operating Margin for 2006, Down 1 Percent from 2005 2
(Date:7/6/2015)... 6, 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ... has resigned from the Company,s Board of Directors in ... a co-founder of Impax in 1995 and served as ... 2006 until April 2014. Logo - http://photos.prnewswire.com/prnh/20150310/180590LOGO ... President and Chief Executive Officer stated, "We wish to ...
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/6/2015)... 6, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced that its board of directors has received a ... Simin Zhang , chairman of the board of ... Ltd., an investment vehicle wholly owned by Mr. Zhang(" ...
Breaking Medicine Technology:Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6
... Mass., Oct. 20, 2011 Boston Scientific Corporation (NYSE: ... 30, 2011, as well as updated sales and earnings per share ... Third quarter and other highlights: ... per share and adjusted EPS of $0.15, both exceeding previous guidance ...
... 20, 2011 OncoSec Medical Incorporated (OTCBB: ONCS), which ... treatment of solid tumor cancers, announced today the submission ... Food and Drug Administration (FDA) for its patented ... generator and hand-held applicator. The Company has been developing ...
Cached Medicine Technology:Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 2Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 3Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 4Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 5Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 6Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 7Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 8Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 9Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 10Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 11Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 12Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 13Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 14Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 15Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 16Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 17Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 18Boston Scientific Exceeds Third Quarter EPS Guidance, Repurchases 30 Million Shares 19Device Master File for OncoSec Medical System Completed and Submitted to FDA 2Device Master File for OncoSec Medical System Completed and Submitted to FDA 3
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical ...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
Introducing Optronics DVMR, the first digital surgical documentation system designed for the microsurgical operating room environment. DVMR accepts images from a variety of high-resolution cameras fo...
Research Grade Microscope Camera from ImagingPlanet Research Microscopy Group, a superior imaging technology that delivers increased image resolution and precise color accuracy at an affordable pric...
Medicine Products: